Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04851691 · ClinicalTrials.gov registry record · NA

An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
158
Enrollment target

NCT04851691 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 158 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04851691, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
158 participants
Enrollment target

Study Summary

The goal of this study will be to design, implement and test the impact of a quality improvement (QI) intervention that uses an EHR CDS tool among physicians newly ordering an antipsychotic medication for older adults with ADRD. The study team hypothesizes that the intervention will reduce each participating clinician's pill days per patient prescribed.

Interventions

  • OTHER Usual Care
  • BEHAVIORAL EHR CDS

Trial Details

FieldValue
Enrollment Target 158 participants
Start Date 2021-08-03
Est. Completion 2023-08-14
Phase NA

What the Registry Record Tells You About NCT04851691

The ClinicalTrials.gov registry entry for NCT04851691 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT04851691 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04851691 about?

NCT04851691 is a clinical study titled "An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions". The goal of this study will be to design, implement and test the impact of a quality improvement (QI) intervention that uses an EHR CDS tool among physicians newly ordering an antipsychotic medication for older adults with ADRD. The study team hypothesizes that the intervention will reduce each part...

What is the current status of trial NCT04851691?

This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2021-08-03. Estimated completion is 2023-08-14.

What interventions are being tested in trial NCT04851691?

The interventions under investigation include: Usual Care (OTHER), EHR CDS (BEHAVIORAL).

Who is sponsoring clinical trial NCT04851691?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.